{
  "cik": 1111485,
  "cik_padded": "0001111485",
  "entityName": "RxSight, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-071775",
      "filed": "2026-02-25",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3830000.0,
        "cash": 19949000.0,
        "cost_of_revenue": 31470000.0,
        "eps_diluted": -0.95,
        "free_cash_flow": -19341000.0,
        "gross_profit": 103009000.0,
        "net_income": -38944000.0,
        "operating_cash_flow": -15511000.0,
        "operating_income": -48191000.0,
        "revenue": 134479000.0,
        "stockholders_equity": 275683000.0,
        "total_assets": 311814000.0,
        "total_liabilities": 36131000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7659857672945218,
        "leverage": 0.1310599492895826,
        "net_margin": -0.2895916834598711,
        "operating_margin": -0.35835334885000625,
        "revenue_growth_yoy": -0.03893458732053142,
        "roa_avg2y": -0.1235578074707675,
        "roa_period_end": -0.12489496943690788,
        "roe_avg2y": -0.13985466520386194,
        "roe_period_end": -0.14126369779783302
      }
    },
    {
      "accn": "0001193125-26-071775",
      "filed": "2026-02-25",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5440000.0,
        "cash": 16706000.0,
        "cost_of_revenue": 40984000.0,
        "eps_diluted": -0.71,
        "free_cash_flow": -22386000.0,
        "gross_profit": 98943000.0,
        "net_income": -27455000.0,
        "operating_cash_flow": -16946000.0,
        "operating_income": -36858000.0,
        "revenue": 139927000.0,
        "stockholders_equity": 281238000.0,
        "total_assets": 318563000.0,
        "total_liabilities": 37325000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7071044187326249,
        "leverage": 0.13271677369345536,
        "net_margin": -0.19620945207143728,
        "operating_margin": -0.2634087774339477,
        "revenue_growth_yoy": 0.5708544293139644,
        "roa_avg2y": -0.1095760836378222,
        "roa_period_end": -0.08618389455147019,
        "roe_avg2y": -0.12434329710144927,
        "roe_period_end": -0.09762194298067829
      }
    },
    {
      "accn": "0001193125-26-071775",
      "filed": "2026-02-25",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4814000.0,
        "cash": 9692000.0,
        "cost_of_revenue": 35312000.0,
        "eps_diluted": -1.41,
        "free_cash_flow": -46407000.0,
        "gross_profit": 53765000.0,
        "net_income": -48608000.0,
        "operating_cash_flow": -41593000.0,
        "operating_income": -50085000.0,
        "revenue": 89077000.0,
        "stockholders_equity": 160362000.0,
        "total_assets": 182550000.0,
        "total_liabilities": 22188000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.6035789260976459,
        "leverage": 0.1383619560743817,
        "net_margin": -0.5456851937088137,
        "operating_margin": -0.56226635382871,
        "revenue_growth_yoy": 0.8177124783185389,
        "roa_avg2y": -0.2921908906748739,
        "roa_period_end": -0.26627225417693784,
        "roe_avg2y": -0.3884537927948087,
        "roe_period_end": -0.3031142041131939
      }
    },
    {
      "accn": "0000950170-25-026681",
      "filed": "2025-02-25",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2393000.0,
        "cash": 11834000.0,
        "cost_of_revenue": 27677000.0,
        "eps_diluted": -2.41,
        "free_cash_flow": -61243000.0,
        "gross_profit": 21328000.0,
        "net_income": -66756000.0,
        "operating_cash_flow": -58850000.0,
        "operating_income": -63318000.0,
        "revenue": 49005000.0,
        "stockholders_equity": 89902000.0,
        "total_assets": 150164000.0,
        "total_liabilities": 60262000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.43522089582695644,
        "leverage": 0.6703076683499811,
        "net_margin": -1.362228344046526,
        "operating_margin": -1.2920722375267828,
        "revenue_growth_yoy": 1.1690346567520913,
        "roa_avg2y": -0.3893783630080056,
        "roa_period_end": -0.4445539543432514,
        "roe_avg2y": -0.5852093414685462,
        "roe_period_end": -0.7425418789348401
      }
    },
    {
      "accn": "0000950170-23-006237",
      "filed": "2023-03-06",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1940000.0,
        "cash": 24361000.0,
        "cost_of_revenue": 18076000.0,
        "eps_diluted": -3.57,
        "free_cash_flow": -46648000.0,
        "gross_profit": 4517000.0,
        "net_income": -48688000.0,
        "operating_cash_flow": -44708000.0,
        "operating_income": -52787000.0,
        "revenue": 22593000.0,
        "stockholders_equity": 138242000.0,
        "total_assets": 192721000.0,
        "total_liabilities": 54479000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.19992918160492187,
        "leverage": 0.39408428697501485,
        "roa_avg2y": -0.33189046960101976,
        "roa_period_end": -0.252634637636791,
        "roe_avg2y": 0.33308135139849976,
        "roe_period_end": -0.352193978675077
      }
    },
    {
      "accn": "0000950170-22-003135",
      "filed": "2022-03-08",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2539000.0,
        "cash": 13994000.0,
        "eps_diluted": 0.15,
        "free_cash_flow": -37742000.0,
        "gross_profit": 1705000.0,
        "net_income": 27575000.0,
        "operating_cash_flow": -35203000.0,
        "operating_income": -35412000.0,
        "stockholders_equity": -430591000.0,
        "total_assets": 100677000.0,
        "total_liabilities": 44906000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_period_end": 0.2738957259354172
      }
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-071775",
    "filed": "2026-02-25",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3851",
  "sic_description": "Ophthalmic Goods",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001111485.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001111485.json"
  },
  "ticker": "RXST"
}